Moreover, our current study provides compelling evidence that hyperglycemia, after activation of oncogenic K-Ras, exerts its pro-tumorigenic effects, at least in part, by maintaining a sub-population of cancer cells, namely tumor-initiating lung bronchio-alveolar stem cells (BASCs). The gene discussed is KRAS; the disease is Hyperglycemia.